John Takyi‐Williams

Therapeutics Systems Research Laboratories (United States)

MedicineChemistryEngineeringImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer”.

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00405

N/A

0DataRank · unranked

58 citations

Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang +16 more

Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01769

N/A

0DataRank · unranked

13 citations

Armita Kyani, Maha Hanafi, Yibin Xu, John Takyi‐Williams, Duxin Sun +3 more